13F HOLDINGS REPORT
Darwin Global Management, Ltd.
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001892688-26-000041
Total Value
$4.94B
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 20,933,277 | $3.64B | 73.78% |
| 2 | BELITE BIO INC | BLTE | 3,027,704 | $486.9M | 9.86% |
| 3 | ABIVAX SA | AAVXF | 3,178,501 | $439.7M | 8.90% |
| 4 | CIDARA THERAPEUTICS INC | 171757206 | 997,196 | $220.2M | 4.46% |
| 5 | WAVE LIFE SCIENCES LTD | WVE | 7,298,421 | $125.2M | 2.53% |
| 6 | CAPRICOR THERAPEUTICS INC | CAPR | 800,000 | $23.2M | 0.47% |